drugset / Trial / NCT01865552
Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB4 in Healthy Male Subjects
RandomizedCrossoverSingle-blindOther
Summary
The purpose of this study is to compare the pharmacokinetics, safety and immunogenicity of SB4 and Enbrel (EU sourced Enbrel and US sourced Enbrel) in healthy male subjects.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | — | Subcutaneous |
| Subject | SB4 | Protein / enzyme biologic | — | Subcutaneous |
Indications
No indication recorded.